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Background: Acute coronary syndromes (ACS) are one of the most common presentations to secondary care. In
addition to established co-morbidities, ethnicity appears to play a signiﬁcant role with South Asians deemed to
be at particular risk.
Methods: An observational, retrospective study was performed to compare prevalence and management of co-
morbidities in male South Asian versus Caucasian populations presenting with ACS. 225 patients were included.
Results: Prevalence of smoking, pre-existing hypertension and hyperlipidaemia was similar. Compliance
with ACE-inhibitors/ARB, beta-blockers and high-dose statins also appeared to be comparable. South
Asians demonstrated a higher prevalence of type 2 diabetes mellitus (DM) compared with Caucasians
(43% versus 19%, p= 0.003), in correlation with higher average BMI (26.3 versus 22.6, p= 0.019). Require-
ments for≥1 oral hypoglycaemic (12% versus 3%, p= 0.030) and insulin therapy (9% versus 4%, p= 0.045)
was greater. South Asians also demonstrated poorer glycaemic control as deﬁned by HbA1c N48 mM (79%
versus 58%, p = 0.004).
Conclusions: Results from this study advocate a particular need to monitor glycaemic control in South Asian
subgroups, who demonstrate preponderance towards type 2 DM. Cultural and language barriers may ac-
count for this disparity and require particular focus.
© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Acute coronary syndromes (ACS) pose a signiﬁcant global health
burden. Recent estimates suggest direct healthcare expenditure and
economic loss related to ACS amounts to £3.6 billion annually in the
UK, whilst the burden to society is valued at up to £9.8 billion [1]. ACS
is an umbrella term and encompasses ST-elevation myocardial infarc-
tion (STEMI), non ST-elevationmyocardial infarction (NSTEMI) and un-
stable angina (UA). These present as acute episodes, with subsequent
management including percutaneous coronary intervention, coronary
artery bypass grafting or pharmacological therapy alone [2]. Despite
such measures, the risk of recurrence of symptoms or complications
from the primary event remains. Subsequent emphasis should therefore
be placed on secondary prevention for patients with ACS.
In the UK, NICE (National Institute of Clinical Excellence) suggest a
multi-faceted framework for secondary prevention in patients present-
ingwith ACS [3]. Initiation of pharmacological therapy is advocated andyal Inﬁrmary, Duckworth Lane,
05 (mobile).
eliability and freedom from bias
d Ltd. This is an open access article unincludes dual anti-platelet therapy, angiotensin blockade, beta-blockers
and high dose statins (atorvastatin 80mgOD or simvastatin 80mgON).
Lifestyle modiﬁcations include advice to adopt a Mediterranean-style
diet and consumption of omega 3 fatty acids to improve lipid proﬁle.
Moderate alcohol consumption within appropriate limits and a regular
daily physical activity for the duration of at least 20–30 min is encour-
aged. Smoking cessation therapy and weight control is emphasised and
options to implement strategies in the primary care setting are outlined.
Other modiﬁable risk factors include hypertension and diabetes, and
management of these often form the cornerstone of measures for sec-
ondary prevention.
Prevalence of coronary events amongst ﬁrst-generation migrants
from South Asia is deemed to be higher than those fromwhite majority
populations [4–6]. Bradford has the highest density of South Asians per
capita in the UK at 20.3%, predominantly originating from Pakistan [7].
Bradford Royal Inﬁrmary (BRI) is the largest district general hospital
within the area that sub-serves this population. This study therefore
sought to compare prevalence and management of co-morbidities in
Caucasian and South Asian sub-populations presenting to BRI with
ACS. It has been commonly observed that sex-based differences in char-
acteristics in such patients exist in any ethnicity and it is often desirable
to analyse men and women separately. For this reason, the study fo-
cused on male subjects only.der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Table 2
Risk factor proﬁles of Caucasian and South Asian sub-populations.
Caucasians
(n = 142)
South Asians
(n = 83)
p-Value
Glycaemic control
Mean HbAlc (mM) 54 62 0.103
HbA1c N 48 mM (%) 58 79 0.004
≥1 Oral hypoglycaemic (%) 3 12 0.030
Insulin therapy (%) 4 9 0.045
Physiological parameters
Mean systolic BP (mm Hg) 130 131 0.237
Mean diastolic BP (mm Hg) 71 74 0.257
BP ≥ 140/90 at follow-up (%) 30 33 0.456
ACE-i/ARB therapy (%) 95 93 0.532
Uptitration of ACE-i/ARB therapy (%) 63 64 0.992
Rate-limiting therapy (%) 97 94 0.440
Resting HR ≤ 60 bpm (%) 45 49 0.264
Lipid proﬁle
Total cholesterol N 4 mM (%) 17 11 0.109
LDL-cholesterol N 2 mM (%) 13 9 0.041
HDL-cholesterol b 1 mM (%) 68 77 0.101
Triglycerides N 2 mM (%) 30 33 0.542
High-dose statin (%) 95 94 0.532
Mean weight (kg) 69.5 76.2 0.013
Mean BMI 22.6 26.3 0.019
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BetweenMarch2012 and September 2013,male patientswere iden-
tiﬁed retrospectively from those presenting to a specialist nurse-led
clinic six weeks post-admissionwith ACS. All patients had this arranged
on discharge as a routine follow-up appointment. Electronic clinic let-
ters and medical notes were scrutinised for data on demographics, bio-
chemical proﬁles and physiological parameters. Biochemical proﬁles
were veriﬁed using the hospital laboratory result server.
All presentationswith acute coronary syndrome that weremanaged
at BRI were included in the study, irrespective of the hospital where in-
tervention occurred, if at all. Patients were excluded if letters ormedical
notes were absent or not retrievable within a reasonable time period.
For readmissions, only the initial presentationwas included in the anal-
ysis. Caucasians were deﬁned as those of European descent. South
Asians were deﬁned as those whose ancestry originated from the
Indian subcontinent (India, Bangladesh, Sri Lanka or Pakistan).
The studywas approved by Bradford Royal Inﬁrmary Audit Commit-
tee (ID3328). Consent was not formally obtained as patient records and
information was anonymised and de-identiﬁed prior to analysis. Data
was collated using Microsoft Excel 2012. Statistical analyses were per-
formed using Minitab 16. Dichotomous variables were compared
using the chi-squared test. A two-sample t test was performed to assess
for differences in means. Statistical signiﬁcance was deﬁned by p b 0.05.
3. Results
3.1. Demographics
238 patients were identiﬁed from the initial retrospective electronic
search. Correspondence was not retrievable in 6 cases. There were 4
cases of readmission and 3 deaths prior to clinic review. Overall, 225 pa-
tients were eligible for inclusion. Demographics of the study groups are
summarised in Table 1. 63% (142/225) were Caucasian and 37% (83/
225) Asian, with similar age distributions (Caucasians: 66.1 years [SD
12.14], Asians: 64.6 years [SD 12.62], p = 0.112). Proportions of STEMI
compared to NSTEMI were as follows: Caucasians (57% [81/142] vs 43%
[61/142]), Asians (43% [36/83] vs 57% [47/83]). Prevalence of current
smokers was comparable (43% [61/142] vs 37% [31/83], p = 0.328). The
presence of pre-existing hypertension (57% [81/142] vs 59% [49/83],
p = 0.489) was also similar.
3.2. Glycaemic control
Risk factor proﬁles for both sub-populations are outlined in Table 2.
The prevalence of diabetes mellitus (DM), deﬁned as 2 h plasma glucose
≥11.1 mmol/L or fasting plasma glucose ≥7.0 mmol/L, was signiﬁcantly
higher in Asians (43%) than Caucasians (19%) with a difference of 24%;
95% CI: 6-35%, p = 0.003. Patients predominantly had DM type 2, with
only two Caucasians having DM type 1. More Asians were on ≥1 oral
hypoglycaemic than Caucasians (12% [10/83] vs 3% [4/142], p = 0.030).
9% (7/83) of Asians were on insulin compared to 4% (6/142) of Cauca-
sians, a difference of 5%; 95% CI: 0.1–12%; p= 0.045.With one exception,
all patients on insulin had been reviewed by the in-reach diabetes serviceTable 1
Demographics of study groups.
Caucasians
(n = 142)
Asians
(n = 83)
p-Value
Age (mean) 66.1 64.6 0.112
FHx of CAD 15 18 0.501
Diabetes mellitus (%) 19 43 0.003
Hypertension (%) 57 59 0.489
Current smoker (%) 43 37 0.328
STEMI (%) 57 43 0.172
NSTEMI (%) 43 57 0.200prior to discharge. At admission, glycaemic control was suboptimal in
both groups. 79% of Asians compared with 58% of Caucasians had a
HbA1c N48 mmol/L, a difference of 21%; 95% CI: 6–48%, p = 0.004.
Mean HbA1c was 62 mmol/L [SD 11.20] in Asians and 54 mmol/L
[SD 14.38] in Caucasians, p = 0.103.
3.3. Physiological parameters (BP and HR)
At follow-up, 30% (43/142) of Caucasians and 33% (27/83) of Asians
had uncontrolled blood pressure (BP≥140/90), a difference of 3% (95%
CI:−0.06–16%, p = 0.456). Mean systolic and diastolic BP was similar
(130 vs 131, p = 0.237; 71 vs 74, p = 0.257). There was no difference
in terms of angiotensin blockade between ethnic groups. 135/142
(95%) of Caucasians were on an angiotensin converting enzyme inhibi-
tor (ACE-i) or angiotensin receptor blocker (ARB), and of these 89/135
(66%) were suitably uptitrated (minimum doubling of dose) with con-
sideration of BP and renal function. Similarly, 77/83 (93%) of Asians
were on an ACE/ARB, and of these, 53/77 (69%)were suitably uptitrated.
97% (138/142) of Caucasians were on rate-limiting therapy (beta-
blocker: 92% [127/138], ivabradine: 8% [11/138]), and in this group,
46% (64/138) had a heart rate (HR) ≤60 beats per minute (bpm). In
comparison, 94% of Asians (78/83) were on rate-limiting therapy
(beta-blocker: 97% [76/78], ivabradine: 3% [2/78]) and 53% of these
(41/78) had a resting HR ≤60 bpm.
3.4. Lipid proﬁle
Target values for lipid proﬁle were deﬁned by UKNICE guidelines [3].
17% (24/142) of Caucasians had total cholesterol N4 mmol/L compared
to 11% (9/83) of Asians (p = 0.109). 13% (18/142) of Caucasians had
LDL N2 mmol/L compared with 9% (7/83) of Asians (p = 0.041). HDL
b1 mmol/L was present in 68% (97/142) of Caucasians, versus 77%
(64/83) of Asians (p= 0.101). Assessment of triglyceride levels revealed
no difference in those with values N2 mmol/L (30% [43/142] vs 33% [27/
83], p= 0.542). Compliancewith high-dose statin therapywas excellent
in both groups (95% [135/142] vs 94% [78/83], p= 0.532). Only one pa-
tient was reported to have discontinued therapy because of an adverse
side-effect. Mean weight in Caucasians was 69.5 kg compared to
76.2 kg in Asians (p = 0.013). Similarly, average BMI was 22.6 (“nor-
mal”) in Caucasians and 26.3 (“overweight”) in Asians, a statistically sig-
niﬁcant difference (p = 0.019).
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Acute coronary syndromes are one of the predominant acute pre-
sentations to secondary care. Recent statistics suggest that around 4%
of hospital admissions in the UK in 2013 were cardiac in origin [8],
hence assessment and management of modiﬁable risk factors is of par-
amount importance in primary and secondary prevention. Established
contributors to the development of coronary artery disease (CAD) in-
clude smoking, diabetes, hypertension and hyperlipidaemia [9,10]. Eth-
nic predisposition is also suggested to play a signiﬁcant role.
South Asians are documented to have a particular predisposition for
CAD.Migrants of ethnic sub groups have shown increased diseasewhen
relocating to developed countries but this was particularly emphasised
in South Asians [5,11,12]. South Asians appear to present earlier with
more extensive, diffuse CAD than other ethnic sub groups [5,11–14]. Ep-
idemiological studies suggest that South Asians have similar levels of
established risk factors for CAD compared to other ethnic groups, except
for a signiﬁcant preponderance towards DM [11,15–17]. Results from
our study corroborate with this observation. Prevalence of smoking,
pre-existing hypertension and hyperlipidaemia appeared to be similar
between the two subgroups analysed. Notably, compliance with ap-
propriate ACE-inhibitor (or ARB), beta-blocker and high-dose statin
therapy was high in both; however, appropriate uptitration of phar-
macological agents based on renal function and physiological param-
eters was less satisfactory in both cohorts. Clinicians in secondary
and primary care must ensure diligence in their approach to
uptitration, in order to maximise control and secondary beneﬁt on
cardiovascular outcomes.
The preponderance towards DM in South Asian cohorts was clearly
apparent in our study (43% versus 21%, p = 0.003). There has been ex-
tensive research into this predisposition, which is likely to involve both
hereditary and environmental inﬂuences [18], but this is beyond the
scope of our discussion. There is a recognised association between cen-
tripetal obesity and development of DM [19,20], and moreover, this is
noted to behigher inmigrant South Asians living in developed countries
than in their native country of origin [21]. Findings from our study cor-
roborate with this, noting statistically signiﬁcant differences in mean
weight and BMI between Caucasians and South Asians. Indeed, sugges-
tions have been made that traditional Body Mass Index (BMI) targets
should be altered for South Asians given their predilection [22–24].
Of relevance, glycaemic control in both ethnic groups was subopti-
mal but signiﬁcantly worse in South Asian groups. Poor diabetic control
has direct implications on predisposition to further cardiovascular
events, and therefore, this disparity is an area that requires speciﬁc at-
tention. Poor regulation of diet and exercise in South Asian subgroups
may be contributory, through effects on centripetal obesity and the con-
sequent metabolic syndrome that heightens insulin resistance [25].
Non-compliance with prescribed pharmacological regimens such as
oral hypoglycaemics and insulin post-discharge is also likely to be impli-
cated, though it is worthy of note that adherence with ACE-inhibitors/
ARB and beta-blockers based on blood pressure and heart rate parame-
ters in clinic appeared to be similar between the two subgroups. Addi-
tionally, one may speculate that cultural and language barriers play a
signiﬁcant role, particularly with regard to regulation of diet and exer-
cise, and this necessitates a particular emphasis on provision of inter-
preters to ensure that patients are adequately informed and that there
is clarity in understanding. Speciﬁc consideration ought to be placed
on aggressive specialist diabetes andnutritional team input, both during
admission and at clinic follow-up.
This study particularly highlights the need for aggressive surveil-
lance of modiﬁable risk factors in populations with ACS, both as inpa-
tients and at subsequent follow up. The provision of a specialist ACS
clinic in the outpatient setting appears to facilitate this, and enables a fo-
cused, rigorous approach to monitoring, compliance and uptitration if
appropriate. Based on the ﬁndings from this study, we advocate partic-
ular need to monitor glycaemic control in South Asian sub-populations,who appear to demonstrate an increased prevalence of type 2 DM. The
relatively lower prevalence of DM amongst Caucasians implies that
other risk factors, such as hypercholesterolaemia, may be more directly
implicated in these cohorts and hence require particular attention.
Theﬁndings fromour study are of direct relevance to healthcare sys-
tems and policy makers, whomust demonstrate a speciﬁc intent to ad-
dress highlighted concerns and reduce burdens on public health. Multi-
centre studies utilising larger sample sizes are clearly warranted to es-
tablish correlations with further clarity.
4.1. Study limitations
As with all observational studies, there are intrinsic limitations
which reduce generalisability of ﬁndings. The relatively small sample
size prevented sufﬁcient power to be generated from statistical analyses
in certain instances. Assimilation of datawas reliant on typed documen-
tation in clinic letters that may not, in all cases, have reﬂected clinical
practice. Of particular note, despite the large relative proportion of
South Asians included in our study (36%), the vast majority of these
were Pakistani in origin (N95%). Patients from India, Bangladesh and
Sri Lanka were signiﬁcantly underrepresented and as a consequence,
potential dissociations between ethnic subgroups within South Asia
may have been neglected; however, one could also argue that this
poses a potential strength as it may allow characterisation of this popu-
lation subset more distinctly.
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